Shuang Jia Selected Research

Shuang Jia Research Topics

Disease

10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 12/2004
8	Inflammation (Inflammations) 01/2022 - 04/2015
6	Neoplasms (Cancer) 10/2023 - 01/2007
3	Wounds and Injuries (Trauma) 02/2024 - 10/2023
3	Infections 01/2020 - 04/2015
3	Endotoxemia 11/2015 - 09/2010
2	Dysbiosis 01/2022 - 01/2022
2	Colitis 04/2016 - 12/2012
2	Sepsis (Septicemia) 11/2015 - 09/2010
1	Autoimmune Diseases (Autoimmune Disease) 05/2024
1	Burns 02/2024
1	Bronchopulmonary Dysplasia 01/2022
1	Insulinoma 01/2022
1	Hyperoxia 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Hemorrhage 12/2020
1	Pseudomonas Infections 01/2019
1	Adenocarcinoma 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Lung Neoplasms (Lung Cancer) 06/2018
1	Disease Progression 01/2018
1	Hemophilia A (Haemophilia) 12/2016
1	Activated Protein C Resistance (APC Resistance) 11/2015
1	Arthrogryposis renal dysfunction cholestasis syndrome 06/2015
1	Glucose Intolerance 09/2014
1	Weight Loss (Weight Reduction) 12/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2012
1	Body Weight (Weight, Body) 12/2012
1	Leukemia 06/2011
1	Virus Diseases (Viral Diseases) 09/2007
1	Human Influenza (Influenza) 09/2007

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 02/2024 - 06/2011
3	Insulin (Novolin)FDA Link 05/2024 - 12/2004
3	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2023
3	HydrogelsIBA 02/2024 - 10/2023
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2010
2	Keratin-14 (Keratin 14)IBA 12/2023 - 10/2023
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 12/2012
2	C-PeptideIBA 11/2018 - 04/2016
2	Phosphotransferases (Kinase)IBA 10/2017 - 06/2017
2	AnticoagulantsIBA 11/2015 - 09/2010
2	Protein CIBA 11/2015 - 09/2010
2	Endothelial Protein C ReceptorIBA 04/2015 - 09/2010
1	Streptozocin (Streptozotocin)FDA Link 02/2024
1	Oxidants (Oxidizing Agents)IBA 12/2023
1	ZincIBA 10/2023
1	CollagenIBA 10/2023
1	Lamin Type B (Lamin B)IBA 10/2023
1	Coloring Agents (Dyes)IBA 10/2023
1	Glutens (Glutelin)IBA 01/2022
1	ursodoxicoltaurineIBA 01/2022
1	AntigensIBA 01/2022
1	Butyrates (Butyrate)IBA 01/2022
1	Caseins (Casein)FDA Link 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	PropionatesIBA 01/2022
1	TunicamycinIBA 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2020
1	Drug CombinationsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Abatacept (Orencia)FDA Link 11/2018
1	1,2,3,4-tetrahydroquinolineIBA 06/2018
1	Fluorescein-5-isothiocyanate (FITC)IBA 06/2018
1	Acridine OrangeIBA 06/2018
1	QuinazolinesIBA 06/2018
1	Propidium (Propidium Iodide)IBA 06/2018
1	Pattern Recognition ReceptorsIBA 01/2018
1	ChemokinesIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 10/2017
1	pyrazoleIBA 10/2017
1	7-azaindole dimerIBA 06/2017
1	CarbohydratesIBA 01/2017
1	Factor VIII (Coagulation Factor VIII)IBA 12/2016
1	canakinumab FDA Link 04/2016
1	Interleukin-1 (Interleukin 1)IBA 04/2016
1	Protein SIBA 11/2015
1	MetalsIBA 06/2015
1	Thromboplastin (Tissue Factor)IBA 04/2015
1	InterferonsIBA 04/2015
1	LipopolysaccharidesIBA 04/2015
1	Cell Surface ReceptorsIBA 04/2015
1	Blood Coagulation Factors (Coagulation Factor)IBA 04/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2013
1	Cysteine (L-Cysteine)FDA Link 02/2013
1	InterleukinsIBA 10/2010
1	Peptide Hydrolases (Proteases)FDA Link 09/2010
1	Peptides (Polypeptides)IBA 09/2007
1	AntibodiesIBA 09/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2007
1	Y glycolipidIBA 01/2007
1	FucosyltransferasesIBA 01/2007
1	FucoseIBA 01/2007

Therapy/Procedure

3	Therapeutics 01/2021 - 09/2010
2	Immunotherapy 04/2016 - 12/2012
1	Thrombolytic Therapy 12/2020
1	Ligation 01/2018
1	Treatment Delay 02/2013